Trials / Not Yet Recruiting
Not Yet RecruitingNCT06895187
Catheter Ablation Using a Novel Navigation and Imaging System
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- LUMA Vision Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VERAFEYE System | VERAFEYE system guidance will be used on all patients undergoing PAF ablation. |
Timeline
- Start date
- 2026-08-01
- Primary completion
- 2027-08-01
- Completion
- 2027-08-01
- First posted
- 2025-03-26
- Last updated
- 2026-04-14
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06895187. Inclusion in this directory is not an endorsement.